Prothena Corp. Public Ltd. Co. (PRTA) stock forecast and price target
Price $8.16 · data as of November 13, 2026
12-month price target
Average target$21.40
Upside / downside+162.3%
Analysts5
ConsensusBuy
Low $8.00Average $21.40High $36.00
Gold marker: average target · white marker: today’s price ($8.16)
Analyst ratings
Strong buy 2Buy 2Hold 2Sell 0Strong sell 1
Earnings and revenue estimates
| Period | EPS estimate | EPS growth | Revenue estimate |
|---|---|---|---|
| Current fiscal year ends December 31, 2026 | $0.66 | +116.5% | $72M |
| Next fiscal year ends December 31, 2027 | $-1.24 | −289.3% | $21M |
| Next quarter ends December 31, 2026 | $0.53 | +214.9% | $20M |
| Quarter after ends March 31, 2027 | $-0.36 | −152.7% | $0 |
Consensus of the analysts covering Prothena Corp. Public Ltd., updated daily. In the last 30 days 2 estimates were raised and 0 lowered.
Frequently asked questions
What is the Prothena Corp. Public Ltd. stock price target?
The average 12-month target from 5 analysts is $21.40, 162.3% above the current price of $8.16 Targets range from $8.00 to $36.00.
Is Prothena Corp. Public Ltd. a buy according to analysts?
The consensus rating is “Buy” (2 strong buy, 2 buy, 2 hold, 1 strong sell). Ratings are opinions, not guarantees; this is not investment advice.
How much is Prothena Corp. Public Ltd. expected to earn?
Analysts expect EPS of $0.66 for the fiscal year ending December 31, 2026 and $-1.24 the year after.
Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.